Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LORAZEPAM Cause Incorrect product administration duration? 34 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Incorrect product administration duration have been filed in association with LORAZEPAM (Lorazepam). This represents 0.1% of all adverse event reports for LORAZEPAM.

34
Reports of Incorrect product administration duration with LORAZEPAM
0.1%
of all LORAZEPAM reports
2
Deaths
4
Hospitalizations

How Dangerous Is Incorrect product administration duration From LORAZEPAM?

Of the 34 reports, 2 (5.9%) resulted in death, 4 (11.8%) required hospitalization, and 3 (8.8%) were considered life-threatening.

Is Incorrect product administration duration Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 34 reports have been filed with the FAERS database.

What Other Side Effects Does LORAZEPAM Cause?

Drug ineffective (3,775) Drug abuse (3,741) Toxicity to various agents (2,836) Completed suicide (2,340) Off label use (2,178) Somnolence (2,114) Sopor (2,042) Anxiety (1,573) Fall (1,524) Overdose (1,516)

What Other Drugs Cause Incorrect product administration duration?

ETONOGESTREL (3,974) POLYETHYLENE GLYCOL 3350 (2,129) NIRMATRELVIR\RITONAVIR (744) DOCOSANOL (634) LANSOPRAZOLE (564) LOPERAMIDE (543) NAPROXEN (499) INSULIN LISPRO (479) DICLOFENAC (362) OMEPRAZOLE (302)

Which LORAZEPAM Alternatives Have Lower Incorrect product administration duration Risk?

LORAZEPAM vs LORCASERIN LORAZEPAM vs LORLATINIB LORAZEPAM vs LORMETAZEPAM LORAZEPAM vs LORNOXICAM LORAZEPAM vs LOSARTAN

Related Pages

LORAZEPAM Full Profile All Incorrect product administration duration Reports All Drugs Causing Incorrect product administration duration LORAZEPAM Demographics